European Archives - Page 1034 of 1282 - European Medical Journal

EMJ

An Interview with Dr Harry Antoniades at The Liver Day: New Perspectives in Clinical Hepatology 2017

During the event ‘The liver day: New perspectives in clinical hepatology 2017’ on Wednesday 8th November 2017, organised by the Royal Society of Medicine…

New Generation of Remote-Controlled Nanorobots Developed

NANOROBOTS that have the potential to diagnose disease and deliver drugs from within the human body have been created by a team of researchers…

Introducing the European Medical Journal 2.4

United Kingdom, November 30, 2017: The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4.

Potential

Way back at the beginning of the year, when I was asked to create content and a schedule for the Future Leaders blog posts, I decided that I would write…

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…

Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B

London & Manchester, UK, 27 November, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company…

EMJ

Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach

The symposium took place on 15th September 2017 as part of the European Academy of Dermatology and Venereology (EADV) Congress in Geneva, Switzerland.

How to Implement Guidelines into Clinical Practice

National and international guidelines are available for almost all common diseases, and these should be applied when counselling patients.

The Treatment Approach of Idiopathic Inflammatory Myopathies

This commentary reflects our personal approach to the treatment of idiopathic inflammatory myopathies (IIM), also commonly referred to as myositis.